Concourse Financial Group Securities’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $930 | Hold |
|
|||||
|
2024
Q3 | $1.05K | Sell |
|
|||||
|
2024
Q2 | $4.2K | Sell |
|
|||||
|
2024
Q1 | $392K | Buy |
|
|||||
|
2023
Q4 | $409K | Sell |
|
|||||
|
2023
Q3 | $396K | Buy |
|
|||||
|
2023
Q2 | $362K | Buy |
|
|||||
|
2023
Q1 | $362K | Buy |
|
|||||
|
2022
Q4 | $271K | Sell |
|
|||||
|
2022
Q3 | $255K | Sell |
|
|||||
|
2022
Q2 | $261K | Sell |
|
|||||
|
2022
Q1 | $395K | Sell |
|
|||||
|
2021
Q4 | $918K | Buy |
|
|||||
|
2021
Q3 | $780K | Buy |
|
|||||
|
2021
Q2 | $734K | Buy |
|
|||||
|
2021
Q1 | $550K | Buy |
|
|||||
|
2020
Q4 | $219K | Buy |
|
|||||
|
2020
Q3 | $83K | Buy |
|
|||||
|
2020
Q2 | $13K | Buy |
|
|||||
|
2020
Q1 | $7K | Buy |
|
|||||
|
2019
Q4 | $7K | Buy |
|
|||||
|
2019
Q3 | $2K | Sell |
|
|||||
|
2019
Q2 | $48K | Buy |
|
|||||
|
2019
Q1 | $15K | Buy |
|
|||||
|
2018
Q4 | $9K | Sell |
|
|||||
|
2018
Q3 | $16K | Buy |
|